News
-
-
-
-
PRESS RELEASE
LUMIBIRD: Photonics confirms strong growth with a 15.3% increase in the first half of 2026
LUMIBIRD Group (FR0000038242 – LBIRD) reports a strong 15.3% growth in Photonics division in the first half of 2026, driven by Defense & Space, Photonic Medtech, and Industrial & Scientific. Medical division shows stability and growth. Regional breakdown highlights growth in Americas and Asia-Pacific -
PRESS RELEASE
VALBIOTIS SA: Cardiovascular Prevention Act: A response to a major public health challenge A milestone fully aligned with Valbiotis’ mission
Valbiotis welcomes the final adoption of the Cardiovascular Prevention Act by the French Parliament, emphasizing prevention of cardiovascular and neurovascular diseases in France's national strategy -
-
-
-
-